CASE REPORT
Accepted on 03 Apr 2025
Possible Tacrolimus-associated seronegative Autoimmune Encephalitis presenting with subacute cognitive impairment and disorientation - Case report
doi 10.3389/fmed.2025.1540960
- Frontiers in Medicine
- Geriatric Medicine
- Research Topics
- Inflammation in the Elderly: Therapeutic Drugs and Strategies
Inflammation in the Elderly: Therapeutic Drugs and Strategies
3,029
Total downloads
10k
Total views and downloads
Submit your idea
You will be redirected to our submission process.
Articles
STUDY PROTOCOL
Published on 24 Jan 2025
Efficacy and safety of Xiongzhitongluo granules in the treatment of acute ischemic stroke: study protocol for a randomized controlled trial
doi 10.3389/fmed.2024.1507278
- 489 views
ORIGINAL RESEARCH
Published on 13 Jan 2025
The change of inflammatory markers may predict long-term major adverse cardiovascular events in elderly patients with coronary heart disease: a retrospective cohort study
doi 10.3389/fmed.2024.1523581
- 435 views
ORIGINAL RESEARCH
Published on 22 Aug 2024
The overall and smoking-attributable burden of multiple sclerosis among older adults aged 65–89 years from 1990 to 2019 and predictions to 2040
doi 10.3389/fmed.2024.1430741
- 1,326 views
REVIEW
Published on 19 Jul 2024
Treatment of neovascular age-related macular degeneration with anti-vascular endothelial growth factor drugs: progress from mechanisms to clinical applications
doi 10.3389/fmed.2024.1411278
- 1,916 views
- 1 citation
REVIEW
Published on 21 May 2024
Inflammation and coronary microvascular disease: relationship, mechanism and treatment
doi 10.3389/fcvm.2024.1280734
- 1,662 views
- 2 citations
ORIGINAL RESEARCH
Published on 09 Jun 2023
New anti-diabetic drug Morus alba L. (Sangzhi) alkaloids (SZ-A) improves diabetic nephropathy through ameliorating inflammation and fibrosis in diabetic rats
doi 10.3389/fmed.2023.1164242
- 2,071 views
- 3 citations
Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.
Submit your idea
You will be redirected to our submission process.